Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown

Cytokine signaling in the epidermis has an important role in maintaining barrier function and is perturbed in pathological conditions. Environmental exposures, such as to metal compounds, are of interest for their potential contribution to skin disease. Present work explores the possibility that van...

Full description

Bibliographic Details
Main Authors: Brian V. Hong, Ji H. Lee, Robert H. Rice
Format: Article
Language:English
Published: PeerJ Inc. 2020-08-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/9504.pdf
_version_ 1797418812129148928
author Brian V. Hong
Ji H. Lee
Robert H. Rice
author_facet Brian V. Hong
Ji H. Lee
Robert H. Rice
author_sort Brian V. Hong
collection DOAJ
description Cytokine signaling in the epidermis has an important role in maintaining barrier function and is perturbed in pathological conditions. Environmental exposures, such as to metal compounds, are of interest for their potential contribution to skin disease. Present work explores the possibility that vanadate is a more effective protein tyrosine phosphatase inhibitor in human keratinocytes than previously observed in fibroblasts. It focuses on the state of phosphorylation of signal transducer and activator of transcription 1 (STAT1) on tyrosine 701 upon treatment of cultured human keratinocytes with the cytokine oncostatin M, a cutaneous inflammatory mediator that is highly effective in suppressing several differentiation markers and in preserving proliferative potential of keratinocytes. Exposure to sodium vanadate in the medium greatly prolonged the phosphorylation of STAT1, but only at high concentration (>30 µM). Inhibitors of protein tyrosine phosphatases known to dephosphorylate STAT1 (SHP2, TCPTP, PTP1B) were ineffective in mimicking the action of vanadate. The irreversible protein tyrosine phosphatase inhibitor phenyl vinyl sulfonate alone induced STAT1 phosphorylation and appeared to induce its limited cleavage. It also inhibited cross-linked envelope formation, a characteristic step of keratinocyte terminal differentiation, likely due to its reaction with the active site cysteine of keratinocyte transglutaminase. Thus, the key protein tyrosine phosphatase responsible for STAT1 dephosphorylation remains to be identified, and an off-target effect of a potential inhibitor was revealed.
first_indexed 2024-03-09T06:39:23Z
format Article
id doaj.art-85c43afbd8cb440c99871b3db6eb3faf
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:39:23Z
publishDate 2020-08-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-85c43afbd8cb440c99871b3db6eb3faf2023-12-03T10:54:05ZengPeerJ Inc.PeerJ2167-83592020-08-018e950410.7717/peerj.9504Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknownBrian V. Hong0Ji H. Lee1Robert H. Rice2Department of Environmental Toxicology and Forensic Science Program, University of California, Davis, CA, United States of AmericaDepartment of Environmental Toxicology and Forensic Science Program, University of California, Davis, CA, United States of AmericaDepartment of Environmental Toxicology and Forensic Science Program, University of California, Davis, CA, United States of AmericaCytokine signaling in the epidermis has an important role in maintaining barrier function and is perturbed in pathological conditions. Environmental exposures, such as to metal compounds, are of interest for their potential contribution to skin disease. Present work explores the possibility that vanadate is a more effective protein tyrosine phosphatase inhibitor in human keratinocytes than previously observed in fibroblasts. It focuses on the state of phosphorylation of signal transducer and activator of transcription 1 (STAT1) on tyrosine 701 upon treatment of cultured human keratinocytes with the cytokine oncostatin M, a cutaneous inflammatory mediator that is highly effective in suppressing several differentiation markers and in preserving proliferative potential of keratinocytes. Exposure to sodium vanadate in the medium greatly prolonged the phosphorylation of STAT1, but only at high concentration (>30 µM). Inhibitors of protein tyrosine phosphatases known to dephosphorylate STAT1 (SHP2, TCPTP, PTP1B) were ineffective in mimicking the action of vanadate. The irreversible protein tyrosine phosphatase inhibitor phenyl vinyl sulfonate alone induced STAT1 phosphorylation and appeared to induce its limited cleavage. It also inhibited cross-linked envelope formation, a characteristic step of keratinocyte terminal differentiation, likely due to its reaction with the active site cysteine of keratinocyte transglutaminase. Thus, the key protein tyrosine phosphatase responsible for STAT1 dephosphorylation remains to be identified, and an off-target effect of a potential inhibitor was revealed.https://peerj.com/articles/9504.pdfCytokinesPVSNSTAT1TransglutaminaseVanadate
spellingShingle Brian V. Hong
Ji H. Lee
Robert H. Rice
Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
PeerJ
Cytokines
PVSN
STAT1
Transglutaminase
Vanadate
title Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
title_full Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
title_fullStr Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
title_full_unstemmed Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
title_short Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
title_sort off target effects of protein tyrosine phosphatase inhibitors on oncostatin m treated human epidermal keratinocytes the phosphatase targeting stat1 remains unknown
topic Cytokines
PVSN
STAT1
Transglutaminase
Vanadate
url https://peerj.com/articles/9504.pdf
work_keys_str_mv AT brianvhong offtargeteffectsofproteintyrosinephosphataseinhibitorsononcostatinmtreatedhumanepidermalkeratinocytesthephosphatasetargetingstat1remainsunknown
AT jihlee offtargeteffectsofproteintyrosinephosphataseinhibitorsononcostatinmtreatedhumanepidermalkeratinocytesthephosphatasetargetingstat1remainsunknown
AT roberthrice offtargeteffectsofproteintyrosinephosphataseinhibitorsononcostatinmtreatedhumanepidermalkeratinocytesthephosphatasetargetingstat1remainsunknown